Лучшие больницы для «Cervical Cerclage (Cervical Stitch)» в Дубай, ОАЭ

In India, cervical cerclage (cervical stitch) typically costs between USD 800 and USD 2,500 depending on the surgical technique used, the gestational complexity, and the hospital's accreditation tier. A straightforward McDonald cerclage performed at a NABH- or JCI-accredited hospital in Mumbai, Delhi, or Chennai generally falls in the USD 800–1,200 range, while a laparoscopic transabdominal cerclage (TAC) at a specialist maternal-fetal medicine centre will be at the upper end of that range, approximately USD 1,800–2,500 inclusive of anaesthesia, post-operative stay, and follow-up ultrasound. In the UAE (Dubai and Abu Dhabi), the same procedures are priced at USD 2,000–5,500, reflecting the higher operating costs of JCI- and DHA-accredited facilities in the Gulf. A McDonald cerclage at a major Dubai hospital typically costs USD 2,000–3,000, while laparoscopic TAC at a subspecialty centre such as Cleveland Clinic Abu Dhabi may reach USD 4,500–5,500. These estimates generally include the surgeon's fee, anaesthesia, operating theatre charges, one overnight hospital stay, and routine post-procedure medications. Additional costs to budget for include the pre-procedure diagnostic workup (TVUS, cultures, blood tests: approximately USD 150–400 in India, USD 300–700 in UAE), accommodation during the mandatory in-country observation period, and return travel. GAF Healthcare provides a transparent, itemised cost estimate specific to each patient's clinical scenario before travel is confirmed.

The minimum recommended in-country stay following cervical cerclage before international air travel is cleared is 2 weeks for uncomplicated prophylactic or ultrasound-indicated McDonald cerclage, and 3–4 weeks for rescue (emergency) cerclage or laparoscopic transabdominal cerclage. This observation period is clinically essential — not simply a precaution — because the most serious post-procedural complications (premature rupture of membranes, chorioamnionitis, acute cervical shortening, and early suture displacement) typically manifest within the first 14–21 days. Before fit-to-fly clearance is issued by the treating maternal-fetal medicine specialist, the patient must complete: a follow-up transvaginal ultrasound at 10–14 days confirming stable suture position and no significant reduction in residual cervical length above the cerclage; clinical assessment confirming the absence of fever, uterine contractions, or vaginal discharge suggestive of infection or membrane rupture; and, for laparoscopic TAC patients, wound site review. Long-haul air travel (flights > 4 hours) poses specific risks in pregnancy — including venous thromboembolism, dehydration, and reduced access to emergency obstetric care — which makes the post-cerclage clearance assessment particularly important. GAF Healthcare's case managers track all follow-up appointments and confirm fit-to-fly status with the treating team before flight arrangements are finalised, and all patients receive a detailed clinical summary in English (and their preferred language) for immediate presentation to their home obstetrician upon return.

The overall success rate of cervical cerclage — defined as prolongation of pregnancy to 34 weeks or beyond — ranges from 75% to 85% for properly selected candidates across all major technique categories. Success rates vary meaningfully based on the indication for cerclage, gestational age at placement, and degree of cervical dilation at the time of the procedure. For history-indicated (prophylactic) cerclage placed at 12–14 weeks in women with a clear history of cervical incompetence, success rates reach 85–90%, with the majority of patients delivering at or near term (≥ 37 weeks). For ultrasound-indicated cerclage placed for a short cervix (< 25 mm) at 16–24 weeks, the MFMU (Maternal-Fetal Medicine Units Network) randomised trial demonstrated a 45% reduction in preterm birth before 35 weeks compared to expectant management in singleton pregnancies, translating to an absolute success rate (delivery ≥ 34 weeks) of approximately 75–80%. Rescue cerclage for an acutely dilated cervix with bulging membranes carries a lower but clinically meaningful success rate of 55–70% for achieving delivery beyond 28 weeks; median pregnancy prolongation in rescue cerclage series is 5–9 weeks, which represents a critical window for fetal lung maturation and improved neonatal survival. Laparoscopic transabdominal cerclage (TAC), when performed in women who have failed prior vaginal cerclage, achieves success rates (delivery ≥ 34 weeks) of 88–95% in specialist series, representing the highest efficacy available. Concurrent use of vaginal micronized progesterone supplementation alongside cerclage has been shown in meta-analyses to additively reduce the risk of preterm birth by a further 30–40% in women with a prior preterm birth history, improving overall outcomes above the cerclage-alone figures. The experienced MFM specialists coordinated through GAF Healthcare at NABH/JCI-accredited hospitals in India and JCI/DHA-licensed centres in the UAE perform these procedures at high volume, which independently correlates with improved technical outcomes and reduced procedure-related complications.